Rethinking the Use of Voriconazole Therapeutic Drug Monitoring in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1705012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Drug Resistant CMV in Pediatric Hematopoietic Stem Cell Transplant Recipients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Frontiers in Microbiology
Microbiology
2019English

Transplant-Associated Microangiopathy (TAM) in Recipients of Allogeneic Hematopoietic Stem Cell Transplants

Bone Marrow Transplantation
TransplantationHematology
2005English

Medication Adherence Among Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Pilot Single-Center Study

Bone Marrow Transplantation
TransplantationHematology
2017English

CMV and EBV DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplant Recipients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Central Nervous System Aspergillosis in Allogeneic Stem Cell Transplant Recipients

Bone Marrow Transplantation
TransplantationHematology
2003English

Therapeutic Drug Monitoring of Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Patients Who Develop Gastrointestinal Graft-Versus-Host Disease

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2012English

Bone Density Loss Following Allogeneic Hematopoietic Stem Cell Transplant

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Analysis of Bacteremia in Allogeneic Stem Cell Transplant Recipients Before Engraftment

Kitakanto Medical Journal
Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy